Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2026 Jan;15(1):e70016.
doi: 10.1002/cpdd.70016.

Assessment of the Intestinal CYP3A Contribution to Drug Interactions with Extended-Release Tacrolimus (LCPT) Using Grapefruit Juice

Affiliations
Randomized Controlled Trial

Assessment of the Intestinal CYP3A Contribution to Drug Interactions with Extended-Release Tacrolimus (LCPT) Using Grapefruit Juice

Adekunle Alabi et al. Clin Pharmacol Drug Dev. 2026 Jan.

Abstract

Grapefruit juice (GFJ) is a known inhibitor of intestinal cytochrome P450 3A (CYP3A) metabolism leading to increased exposure to CYP3A substrates such as tacrolimus. The extended-release tacrolimus formulation Envarsus (LCPT) exhibits prolonged absorption throughout the entire GI tract. Although a clinically significant drug-drug interaction occurs with immediate-release tacrolimus formulations, this has not been evaluated with extended-release formulations. This study assessed the impact of GFJ on LCPT in adult kidney transplant patients. Eleven adult kidney transplant recipients on a stable dose of LCPT were enrolled in a randomized crossover study. Participants were administered either GFJ or water during each pharmacokinetic visit, with midazolam used as a positive control. A washout period of 2-4 weeks was included between visits. Tacrolimus concentrations were determined using validated LC-MS/MS methods. Tacrolimus AUC0-24 was 28% higher with GFJ (GMR = 1.28, 90% CI 1.12-1.44) and Cmax was 73% higher (GMR = 1.73, 90% CI 1.46-2.00) compared to control. GFJ exhibited a clinically meaningful interaction with LCPT. However, the magnitude appears less than those reported with immediate-release formulations, suggesting the extended absorption profile of LCPT may affect susceptibility to drug interactions in the intestine.

Keywords: Envarsus; LC‐MS/MS; cytochrome P450 3A; drug–drug interactions; grapefruit juice; midazolam; tacrolimus.

PubMed Disclaimer

Conflict of interest statement

Shirley M. Tsunoda received funding from Veloxis Pharmaceuticals; all other co‐authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Pharmacokinetic profiles of extended‐release tacrolimus (LCPT) and midazolam in participants over 24 h in the presence of grapefruit juice. Concentrations expressed as mean ± standard error of the mean (n = 11).

References

    1. Henkel L, Jehn U, Thölking G, Reuter S. Tacrolimus—why pharmacokinetics matter in the clinic. Front Transplant. 2023;2:1160752. - PMC - PubMed
    1. Taylor PJ, Hogan NS, Lynch SV, Johnson AG, Pond SM. Improved therapeutic drug monitoring of tacrolimus (FK506) by tandem mass spectrometry. Clin Chem. 1997;43(11):2189‐2190. - PubMed
    1. Miedziaszczyk M, Bajon A, Jakielska E, et al. Controversial interactions of tacrolimus with dietary supplements, herbs and food. Pharmaceutics. 2022;14(10):2154. - PMC - PubMed
    1. Lynch T, Price A. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Fam Physician. 2007;76(3):391‐396. - PubMed
    1. Gertz M, Davis J, Harrison A, Houston J, Galetin A. Grapefruit juice‐drug interaction studies as a method to assess the extent of intestinal availability: utility and limitations. Curr Drug Metab. 2008;9(8):785‐795. - PubMed

Publication types

MeSH terms

Grants and funding

LinkOut - more resources